Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.
Valenza C, Trapani D, Zagami P, Antonarelli G, Boscolo Bielo L, Nicolò E, Ribeiro JM, Guidi L, Reduzzi C, Spotti M, Adamoli L, Cortès J, Pistilli B, Tolaney SM, Ueno N, Layman RM, Cristofanilli M, Carey LA, Munzone E, Criscitiello C, Lynce F, Woodward WA, Curigliano G. Valenza C, et al. Among authors: cristofanilli m. Eur J Cancer. 2024 Dec;213:115097. doi: 10.1016/j.ejca.2024.115097. Epub 2024 Oct 28. Eur J Cancer. 2024. PMID: 39486164
Inflammatory breast cancer.
Woodward WA, Cristofanilli M. Woodward WA, et al. Among authors: cristofanilli m. Semin Radiat Oncol. 2009 Oct;19(4):256-65. doi: 10.1016/j.semradonc.2009.05.008. Semin Radiat Oncol. 2009. PMID: 19732690 Review.
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies.
Roviello G, Andre F, Venturini S, Pistilli B, Curigliano G, Cristofanilli M, Rosellini P, Generali D. Roviello G, et al. Among authors: cristofanilli m. Eur J Cancer. 2017 Nov;86:257-265. doi: 10.1016/j.ejca.2017.09.018. Epub 2017 Oct 19. Eur J Cancer. 2017. PMID: 29055841 Free article. Review.
The immunogram of inflammatory breast cancer.
Valenza C, Trapani D, Fusco N, Wang X, Cristofanilli M, Ueno NT, Curigliano G. Valenza C, et al. Among authors: cristofanilli m. Cancer Treat Rev. 2023 Sep;119:102598. doi: 10.1016/j.ctrv.2023.102598. Epub 2023 Jul 8. Cancer Treat Rev. 2023. PMID: 37437342 Review.
Inflammatory breast cancer: the disease, the biology, the treatment.
Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, Cristofanilli M. Robertson FM, et al. Among authors: cristofanilli m. CA Cancer J Clin. 2010 Nov-Dec;60(6):351-75. doi: 10.3322/caac.20082. Epub 2010 Oct 19. CA Cancer J Clin. 2010. PMID: 20959401 Free article. Review.
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer.
Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA. Li J, et al. Among authors: cristofanilli m. Oncologist. 2011;16(12):1675-83. doi: 10.1634/theoncologist.2011-0196. Epub 2011 Dec 6. Oncologist. 2011. PMID: 22147002 Free PMC article.
465 results